跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Decitabine/Gemcitabine
首页
药物
Decitabine/Gemcitabine
Decitabine/Gemcitabine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof
CN 1923173 B
申请人: JINAN KANGQUAN PHARMACEUTICAL CO LTD
优先权: 2006
CN
Anti-cancer drug slow release injection containing gemcitabine
CN 101637444 B
申请人: SHANDONG LANJIN PHARMACEUTICALS CO LTD
优先权: 2006
CN
Gemcitabine-containing anti-cancer medicine sustained-release injection
CN 101427994 B
申请人: SHANDONG LANJIN PHARMACEUTICALS CO LTD
优先权: 2006
CN
Antimetabolites and potentiating agent thereof carried by anticancer sustained-release injection
CN 101297970 A
申请人: SHANDONG LANJIN BIOLOG ENGINEE
优先权: 2006
CN
Slow-released injection containing nolatrexed dihydrochloride and synergist thereof
CN 101416938 A
申请人: SHANDONG LANJIN BIOLOG ENGINEE
优先权: 2006
CN
Anticancer composition loaded with anti-metabolism medicine and synergist thereof
CN 101390828 B
申请人: JINAN KANGQUAN MEDICINE INDUSTRY CO LTD
优先权: 2007
CN
Anticancer composition loaded with anti-metabolism medicine fluorouracil and synergist thereof
CN 101390829 A
申请人: JINAN KANGQUAN MEDICINE INDUST
优先权: 2007
CN
Anticancer composition loaded with anti-metabolism and synergist thereof
CN 101332206 A
申请人: JINAN KANGQUAN MEDICINE SCIENC
优先权: 2007
CN
Antimetabolites mitozolomide and potentiating agent thereof carried by anticancer composition
CN 101485624 A
申请人: JINAN KANGQUAN MEDICINE SCIENC
优先权: 2007
CN
METHOD OF TREATING PATHOLOGIC HETEROTOPIC OSSIFICATION
US 2014220154 A1
申请人: REGARD JEAN
优先权: 2012
US
第 1 / 2 页
上一页
下一页
药物
反馈